| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/12/1997 | US5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules |
| 08/12/1997 | US5656455 Adenylate cyclase stimulating factor |
| 08/12/1997 | US5656269 Peptide plasminogen activators |
| 08/07/1997 | WO1997028183A1 Peptide inhibitors of hematopoietic cell proliferation |
| 08/07/1997 | WO1997028129A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 08/07/1997 | WO1997027870A1 Preventives and remedies for thrombocytopenia |
| 08/07/1997 | WO1997027867A1 Protection of hemopoietic cells |
| 08/07/1997 | WO1997012985A3 Multi-functional hematopoietic receptor agonists |
| 08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
| 08/07/1997 | CA2245085A1 Protection of hemopoietic cells |
| 08/07/1997 | CA2244673A1 Peptide inhibitors of hematopoietic cell proliferation |
| 08/06/1997 | EP0787802A2 Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 08/06/1997 | EP0787185A2 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 08/06/1997 | EP0787181A1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
| 08/06/1997 | EP0787142A1 Neurturin and related growth factors |
| 08/06/1997 | EP0787119A1 Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0787010A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 08/06/1997 | EP0787003A2 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems |
| 08/06/1997 | EP0677107B1 Clotting inhibitor made from protostomia saliva |
| 08/05/1997 | US5654305 Indole piperazine platelet activating factor antagonists |
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | CA1339199C Magnetic protein conjugates, a process for the preparation thereof, and the use thereof |
| 08/05/1997 | CA1339197C A tissue adhesive |
| 07/31/1997 | WO1997027286A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | WO1997027177A2 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 07/31/1997 | WO1997026912A2 Anti-cd18 antibodies for use against stroke |
| 07/31/1997 | WO1997026907A1 Novel administration of thrombopoietin |
| 07/31/1997 | WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2242417A1 Novel administration of thrombopoietin |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786473A2 Basic protein composition, basic peptide composition and application thereof |
| 07/30/1997 | EP0786257A1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785801A1 Treatment of tissues to reduce subsequent response to injury |
| 07/30/1997 | EP0785799A1 Process for production of inhibited forms of activated blood factors |
| 07/30/1997 | CN1155437A Composition extracted from collagen and preparation thereof |
| 07/29/1997 | US5652264 Cyclohexadiene derivatives useful in the treatment of depression |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652219 Hemoregulatory peptides |
| 07/29/1997 | US5651982 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | CA1339189C Amblyommin, a new active substance for anticoagulant therapy |
| 07/29/1997 | CA1339106C Hirullin polypeptides having anticoagulant activity |
| 07/29/1997 | CA1339104C Hirudin derivative |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026250A1 Integrin receptor antagonists |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997017072A3 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2242877A1 Integrin receptor antagonists |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0784673A1 A method of selecting pluripotent hematopoietic progenitor cells |
| 07/23/1997 | EP0784633A1 Process for purifying factor viii |
| 07/23/1997 | EP0784632A1 Process for extracting high-purity von willebrand factor |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0643772B1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/23/1997 | EP0502968B1 Activatable fibrinolytic and anti-thrombotic proteins |
| 07/23/1997 | CN1154851A Blood-enriching agent-Yixuejing and preparation method thereof |
| 07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
| 07/22/1997 | US5650429 Use of DL-(+/-)-α-lipoic acid, D-(+)-α-lipoic acid, α-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/22/1997 | US5650424 Antiagglomerants using imidazolidindiones |
| 07/22/1997 | US5650301 Hirudin HV2 having a SN7LYS substitution, method of making, and method of use |
| 07/22/1997 | US5650299 Cells producing stem cell proliferation factor |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 07/17/1997 | WO1997025343A2 Antithrombotic agents and methods of use |
| 07/17/1997 | WO1997025323A1 Fibrinogen receptor antagonists |
| 07/17/1997 | WO1997025052A2 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025033A1 Antithrombotic diamines |
| 07/17/1997 | CA2242385A1 Antithrombotic agents and methods of use |
| 07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor |
| 07/17/1997 | CA2236007A1 Antithrombotic diamines |
| 07/16/1997 | EP0784058A1 Derivatives of aspartic acid, preparation and use thereof |
| 07/16/1997 | EP0783575A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/16/1997 | EP0783528A1 Method of producing starch decomposition products |
| 07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
| 07/16/1997 | EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |